Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C

NCT00421434 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Nitazoxanide
BIOLOGICAL: Peginterferon alfa-2a
BIOLOGICAL: Peginterferon alfa-2a
DRUG: Ribavirin
DRUG: Ribavirin

Sponsor

Romark Laboratories L.C.